Mai Tanaka-Wakefield

Mai Tanaka-Wakefield currently serves as Associate Director of Corporate Development at Avalyn Pharma Inc., a position held since April 2024. Prior to this role, Mai was a Senior Associate and previously an Associate at Agent Capital from October 2022 to April 2024. Mai's experience also includes serving as a Senior Consultant at Trinity Life Sciences from January 2022 to October 2022. Mai Tanaka-Wakefield holds a Doctor of Philosophy (PhD) in Biomedical Sciences and a Master of Public Health (MPH) in Epidemiology from the University of Florida, along with a Bachelor’s Degree in Biochemistry from New College of Florida. Educational background also includes foundational schooling at the International School of Indiana and Seisen International School.